|
|
News Breaks
|
November 18, 2009
|
| 06:55 EDT |  | COV |
| theflyonthewall.com: | Covidien seems poised to continue growing into FY2010, says Leerink | | After Covidien reported stronger than expected results, Leerink Swann thinks the company is on the right track and the firm reiterates an Outperform rating. :theflyonthewall.com |
|
|
News For COV From The Last 14 Days Check below for free stories on COV the last two weeks.
There are 6 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 09:36 EDT |  | COV |
|
|
February 8, 2012
|
| 23:32 EDT |  | COV |
|
|
February 3, 2012
|
| 07:39 EDT |  | COV |
|
|
February 2, 2012
|
| 14:05 EDT | | COV |
| theflyonthewall.com: | FDA and industry reach agreement in principle on medical device user fees | | The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595M in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon. :theflyonthewall.com |
|
|
February 1, 2012
|
| 16:28 EDT | | COV |
|
|
January 30, 2012
|
| 07:07 EDT | | COV |
| theflyonthewall.com: | Covidien device approved for interventional management of stroke trial | | Covidien announced that the Solitaire FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke trial. The Solitaire FR device was approved by the IMS III Executive Committee in the thrombectomy arm of the trial and was included in a recently approved amendment submitted to the FDA. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information